Ernexa Therapeutics Appoints Dr. Ira S. Winer to Scientific and Medical Advisory Board, Strengthening Expertise in Women's Oncology and Immunotherapy

Tuesday, Dec 2, 2025 8:51 am ET1min read
ERNA--

Ernexa Therapeutics has appointed Dr. Ira S. Winer, M.D., Ph.D., FACOG, to its Scientific and Medical Advisory Board. Dr. Winer is a gynecologic oncologist and translational scientist with expertise in women's oncology, immunotherapy, and early-phase clinical development. His appointment strengthens Ernexa's capabilities as it advances its proprietary induced mesenchymal stem cells (iMSC) platform and lead program, ERNA-101, toward key milestones.

Ernexa Therapeutics Appoints Dr. Ira S. Winer to Scientific and Medical Advisory Board, Strengthening Expertise in Women's Oncology and Immunotherapy

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet